Implantable, polymeric systems for modulated drug delivery.
The ability to deliver therapeutic agents to a patient in a pulsatile or staggered release profile has been a major goal in drug delivery research over the last two decades. This review will cover methods that have been developed to control drug delivery profiles with implantable polymeric systems. Externally and internally controlled systems will be discussed, spanning a range of technologies that include pre-programmed systems, as well as systems that are sensitive to modulated enzymatic or hydrolytic degradation, pH, magnetic fields, ultrasound, electric fields, temperature, light and mechanical stimulation. Implantable systems have the potential to improve the quality of life for patients undergoing therapy with a variable dosing regime by eliminating the need for multiple intravenous injections. Ideally, these systems would also result in increased patient compliance with a given therapy due to the relative ease of self-dosing.
Sershen
S
S
Department of Bioengineering, MS 142, Rice University, Houston, TX 77005, USA.
West
J
J
D001673:Biodegradation, Environmental; D003692:Delayed-Action Preparations / Q000008:administration & dosage*; D016503:Drug Delivery Systems / Q000379:methods*; D004343:Drug Implants; D004574:Electromagnetic Fields; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008027:Light; D008280:Magnetics; D011108:Polymers; D013696:Temperature; D014465:Ultrasonics
D003692:Delayed-Action Preparations; D004343:Drug Implants; D011108:Polymers